Twenty Years of Presenilins--Important Proteins in Health and Disease
- PMID: 26605647
- PMCID: PMC4661050
- DOI: 10.2119/molmed.2015.00163
Twenty Years of Presenilins--Important Proteins in Health and Disease
Abstract
Alzheimer's disease (AD) is characterized by progressive decline in cognitive functions associated with depositions of aggregated proteins in the form of extracellular plaques and neurofibrillary tangles in the brain. Extracellular plaques contain characteristic fibrils of amyloid β peptides (Aβ); tangles consist of paired helical filaments of the microtubuli-associated protein tau. Although AD manifests predominantly at ages above 65 years, rare cases show a much earlier onset of disease symptoms with very similar neuropathological characteristics. In 1995, two homologous genes were identified, in which mutations are associated with dominantly inherited familial forms of early onset AD. The genes therefore were dubbed presenilins (PS) and encode polytopic transmembrane proteins. At this time the role of these proteins in the pathogenesis of AD and their biological function in general were completely unknown. However, individuals carrying PS mutations showed alterations in the composition of different length variants of Aβ peptides in blood and cerebrospinal fluid, which indicated the potential involvement of presenilins in the metabolism of Aβ. After 20 years of intense research, the roles of presenilins in Aβ generation as well as important functions in biological processes have been identified. Presenilins represent the catalytic components of protease complexes that directly cleave the amyloid precursor protein (APP) but also many other proteins with important physiological functions. Here, the progress in presenilin research from basic characterization of their cellular functions to the targeting in clinical trials for AD therapy, and potential future directions, will be discussed.
Figures
Similar articles
-
Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.Curr Protein Pept Sci. 2020;21(12):1164-1173. doi: 10.2174/1389203721666200921152246. Curr Protein Pept Sci. 2020. PMID: 32957903 Review.
-
Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.Am J Pathol. 2017 Aug;187(8):1828-1847. doi: 10.1016/j.ajpath.2017.04.018. Epub 2017 Jun 20. Am J Pathol. 2017. PMID: 28641077
-
Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.Adv Biol Regul. 2017 May;64:33-38. doi: 10.1016/j.jbior.2017.01.001. Epub 2017 Jan 5. Adv Biol Regul. 2017. PMID: 28082052 Review.
-
Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.Acta Neuropathol. 2015 Feb;129(2):163-5. doi: 10.1007/s00401-015-1387-2. Acta Neuropathol. 2015. PMID: 25600324 No abstract available.
-
Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.Neuropathol Appl Neurobiol. 2003 Feb;29(1):35-44. doi: 10.1046/j.1365-2990.2003.00425.x. Neuropathol Appl Neurobiol. 2003. PMID: 12581338
Cited by
-
Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases.Front Cell Neurosci. 2024 Mar 7;18:1359453. doi: 10.3389/fncel.2024.1359453. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38515787 Free PMC article. Review.
-
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.Int J Mol Sci. 2020 Nov 20;21(22):8765. doi: 10.3390/ijms21228765. Int J Mol Sci. 2020. PMID: 33233496 Free PMC article. Review.
-
Early-Onset Familial Alzheimer Disease Variant PSEN2 N141I Heterozygosity is Associated with Altered Microglia Phenotype.J Alzheimers Dis. 2020;77(2):675-688. doi: 10.3233/JAD-200492. J Alzheimers Dis. 2020. PMID: 32741831 Free PMC article.
References
-
- Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med. 2010;362:329–44. - PubMed
-
- Kennedy JL, Farrer LA, Andreasen NC, Mayeux R, St George-Hyslop P. The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science. 2003;302:822–6. - PubMed
-
- Goate A, Hardy J. Twenty years of Alzheimer’s disease-causing mutations. J Neurochem. 2012;120(Suppl 1):3–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical